Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 881; doi:10.1093/annonc/mdl125
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

J. O. Armitage and F. R. Loberiza

Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?
Ann Oncol 17: 883-884; doi:10.1093/annonc/mdl099
[Extract] [Full Text] [PDF] [Request Permissions]

N. I. Cherny, R. Catane, and P. A. Kosmidis

Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering
Annals of Oncology Advance Access published on April 20, 2006
Ann Oncol 17: 885-887; doi:10.1093/annonc/mdl073
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

A. T. Farrell, I. Papadouli, A. Hori, M. Harczy, B. Harrison, W. Asakura, M. Marty, R. Dagher, and R. Pazdur

The advisory process for anticancer drug regulation: a global perspective
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 889-896; doi:10.1093/annonc/mdj099
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. Tanvetyanon and P. J. Stiff

Management of the adverse effects associated with intravenous bisphosphonates
Annals of Oncology Advance Access published on March 17, 2006
Ann Oncol 17: 897-907; doi:10.1093/annonc/mdj105
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

original articles:

hematologic malignancies:

M. Liedtke, P. A. Hamlin, C. H. Moskowitz, and A. D. Zelenetz

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
Annals of Oncology Advance Access published on May 3, 2006
Ann Oncol 17: 909-913; doi:10.1093/annonc/mdl049
[Abstract] [Full Text] [PDF] [Request Permissions]

M. Hentrich, L. Maretta, K. U. Chow, J. R. Bogner, D. Schürmann, P. Neuhoff, H. Jäger, D. Reichelt, M. Vogel, M. Ruhnke, M. Oette, R. Weiß, J. Rockstroh, K. Arasteh, and P. Mitrou

Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
Annals of Oncology Advance Access published on March 24, 2006
Ann Oncol 17: 914-919; doi:10.1093/annonc/mdl063
[Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]

A. K. Ganti, D. D. Weisenburger, L. M. Smith, C. P. Hans, R. G. Bociek, P. J. Bierman, J. M. Vose, and J. O. Armitage

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 920-927; doi:10.1093/annonc/mdl039
[Abstract] [Full Text] [PDF] [Request Permissions]

O. Bairey, O. Benjamini, D. Blickstein, A. Elis, and R. Ruchlemer

Non-Hodgkin's lymphoma in patients 80 years of age or older
Annals of Oncology Advance Access published on February 28, 2006
Ann Oncol 17: 928-934; doi:10.1093/annonc/mdl034
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

B. C. Pestalozzi, D. Zahrieh, K. N. Price, S. B. Holmberg, J. Lindtner, J. Collins, D. Crivellari, M. F. Fey, E. Murray, O. Pagani, E. Simoncini, M. Castiglione-Gertsch, R. D. Gelber, A. S. Coates, and A. Goldhirsch For the International Breast Cancer Study Group

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
Annals of Oncology Advance Access published on April 7, 2006
Ann Oncol 17: 935-944; doi:10.1093/annonc/mdl064
[Abstract] [Full Text] [PDF] [Request Permissions]

F. Andre, N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, J. C. Soria, and M. Cristofanilli

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer
Annals of Oncology Advance Access published on April 20, 2006
Ann Oncol 17: 945-951; doi:10.1093/annonc/mdl053
[Abstract] [Full Text] [PDF] [Request Permissions]

M. E. Trudeau, M. Crump, D. Charpentier, L. Yelle, L. Bordeleau, S. Matthews, and E. Eisenhauer

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)
Annals of Oncology Advance Access published on March 24, 2006
Ann Oncol 17: 952-956; doi:10.1093/annonc/mdl056
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

J. Sehouli, G. Oskay-Özcelik, J. Kühne, D. Stengel, H.-J. Hindenburg, P. Klare, G. Heinrich, B. Schmalfeldt, H. Mertens, O. Camara, and W. Lichtenegger Ovarian Cancer Study Group of the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO)

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial
Annals of Oncology Advance Access published on April 6, 2006
Ann Oncol 17: 957-961; doi:10.1093/annonc/mdl079
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

M. Francoual, M.-C. Etienne-Grimaldi, J.-L. Formento, D. Benchimol, A. Bourgeon, M. Chazal, C. Letoublon, T. André, N. Gilly, J.-R. Delpero, P. Lasser, J.-P. Spano, and G. Milano

EGFR in colorectal cancer: more than a simple receptor
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 962-967; doi:10.1093/annonc/mdl037
[Abstract] [Full Text] [PDF] [Request Permissions]

A. Goto, Y. Yamada, H. Yasui, K. Kato, T. Hamaguchi, K. Muro, Y. Shimada, and K. Shirao

Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer
Annals of Oncology Advance Access published on April 7, 2006
Ann Oncol 17: 968-973; doi:10.1093/annonc/mdl066
[Abstract] [Full Text] [PDF] [Request Permissions]

W. J. Lesterhuis, I. J. M. de Vries, D. H. Schuurhuis, A. C. I. Boullart, J. F. M. Jacobs, A. J. de Boer, N. M. Scharenborg, H. M. H. Brouwer, M. W. M. M. van de Rakt, C. G. Figdor, T. J. Ruers, G. J. Adema, and C. J. A. Punt

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
Annals of Oncology Advance Access published on April 6, 2006
Ann Oncol 17: 974-980; doi:10.1093/annonc/mdl072
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

A. Italiano, F. Burel Vandenbos, J. Otto, J. Mouroux, D. Fontaine, P.-Y. Marcy, N. Cardot, A. Thyss, and F. Pedeutour

Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 981-985; doi:10.1093/annonc/mdl038
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

K. P. Weinfurt, K. J. Anstrom, L. D. Castel, K. A. Schulman, and F. Saad

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer
Annals of Oncology Advance Access published on March 13, 2006
Ann Oncol 17: 986-989; doi:10.1093/annonc/mdl041
[Abstract] [Full Text] [PDF] [Request Permissions]

C. Theodore, F. Bidault, N. Bouvet-Forteau, M. Abdelatif, K. Fizazi, M. di Palma, P. Wibault, R. de Crevoisier, and A. Laplanche

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
Annals of Oncology Advance Access published on April 6, 2006
Ann Oncol 17: 990-994; doi:10.1093/annonc/mdl057
[Abstract] [Full Text] [PDF] [Request Permissions]

head and neck cancer:

S. Demokan, Y. Suoglu, D. Demir, M. Gozeler, and N. Dalay

Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer
Annals of Oncology Advance Access published on March 28, 2006
Ann Oncol 17: 995-999; doi:10.1093/annonc/mdl048
[Abstract] [Full Text] [PDF] [Request Permissions]

supportive care:

H. J. Schmoll, M. S. Aapro, S. Poli-Bigelli, H.-K. Kim, K. Park, K. Jordan, J. von Pawel, H. Giezek, T. Ahmed, and C. Y. Chan

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 1000-1006; doi:10.1093/annonc/mdl019
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

C. Kollmannsberger, M. Schittenhelm, F. Honecker, J. Tillner, D. Weber, K. Oechsle, L. Kanz, and C. Bokemeyer

A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
Annals of Oncology Advance Access published on March 13, 2006
Ann Oncol 17: 1007-1013; doi:10.1093/annonc/mdl042
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

F. Bravi, L. Scotti, C. Bosetti, R. Talamini, E. Negri, M. Montella, S. Franceschi, and C. La Vecchia

Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer
Annals of Oncology Advance Access published on April 12, 2006
Ann Oncol 17: 1014-1017; doi:10.1093/annonc/mdl080
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

clinical trials:

L. H. Schwartz, J. A. C. Colville, M. S. Ginsberg, L. Wang, M. Mazumdar, J. Kalaigian, H. Hricak, D. Ilson, and G. K. Schwartz

Measuring tumor response and shape change on CT: esophageal cancer as a paradigm
Annals of Oncology Advance Access published on April 26, 2006
Ann Oncol 17: 1018-1023; doi:10.1093/annonc/mdl058
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

Y. Merrouche, F. Mugneret, and J.-Y. Cahn

Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer
Annals of Oncology Advance Access published on November 17, 2005
Ann Oncol 17: 1025-1026; doi:10.1093/annonc/mdj082
[Extract] [Full Text] [PDF] [Request Permissions]

G. Ferretti, A. Felici, M. Ciccarese, P. Papaldo, P. Carlini, A. Fabi, A. Gelibter, and F. Cognetti

Molecular stool testing for the early detection of colorectal cancer: swan song for p53?
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 1026; doi:10.1093/annonc/mdj081
[Extract] [Full Text] [PDF] [Request Permissions]

M. Provencio, S. Cerdeira, F. Bonilla, A. Sánchez, and P. España

Rapid-infusion rituximab in lymphoma treatment
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 1027-1028; doi:10.1093/annonc/mdj103
[Extract] [Full Text] [PDF] [Request Permissions]

I. Okamoto, J. Araki, R. Suto, M. Shimada, K. Nakagawa, and M. Fukuoka

EGFR mutation in gefitinib-responsive small-cell lung cancer
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 1028-1029; doi:10.1093/annonc/mdj114
[Extract] [Full Text] [PDF] [Request Permissions]

M. G. Fakih

Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
Annals of Oncology Advance Access published on December 29, 2005
Ann Oncol 17: 1029-1030; doi:10.1093/annonc/mdj118
[Extract] [Full Text] [PDF] [Request Permissions]

J.-P. Machiels and P. Scalliet

Reply to Letter to the Editor ‘Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?’, by M. G. Fakih (Ann Oncol 2006; 17: 1029)
Annals of Oncology Advance Access published on January 3, 2006
Ann Oncol 17: 1030-1031; doi:10.1093/annonc/mdj119
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.